Drugs / B/F/TAF
last change Jun 2025 re-read 2 minutes ago

B/F/TAF

Developed for
HIV infectious disease
Investigated by
Gilead Sciences · Peking Union Medical College Hospital

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04296695 Jul 2021 → Dec 2022 HIV infectious disease Peking Union Medical College Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as B/F/TAF ClinicalTrials.gov intervention name — accepted as the source's own label NCT04296695